<DOC>
	<DOCNO>NCT01649830</DOCNO>
	<brief_summary>Low-grade glioma ( LGG ) common primary brain tumor young adult . The infiltrative nature frequent growth eloquent area brain often make total resection impossible . Until , agreement achieve treatment LGG without total resection . Post-radiation adjuvant temozolomide ( TMZ ) currently standard care high-grade glioma . Radiotherapy TMZ recommend treatment residue low-grade glioma . However , efficacy combine radiotherapy adjuvant TMZ residue LGG remain define . In randomized controlled trial , investigator test hypothesis radiotherapy subsequent TMZ chemotherapy superior improve progression-free survival patient residue LGG without significant impairment quality life compare radiotherapy alone .</brief_summary>
	<brief_title>Efficacy Post-radiation Adjuvant Temozolomide Chemotherapy Residue Low-grade Glioma</brief_title>
	<detailed_description />
	<mesh_term>Glioma</mesh_term>
	<mesh_term>Astrocytoma</mesh_term>
	<mesh_term>Oligodendroglioma</mesh_term>
	<mesh_term>Temozolomide</mesh_term>
	<mesh_term>Dacarbazine</mesh_term>
	<criteria>Age : 18 year 60 year Incompletely resect supratentorial WHO II astrocytoma , oligodendroglioma oligodendroastrocytoma Karnofsky Performance Score â‰¥ 60 Adequate bone marrow , liver renal function Ability subject understand character individual consequence clinical trial Written inform consent Refusal participate study Known hypersensitivity contraindication temozolomide Previous irradiation , prior radiosurgery prior chemotherapy Pregnant lactating female Malignant tumor brain tumor Contraindicated MRI examination Unable comply followup study trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>low-grade glioma</keyword>
	<keyword>radiotherapy</keyword>
	<keyword>chemotherapy</keyword>
</DOC>